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Is the Nexfin finger cuff method for cardiac output measurement reliable
during coronary artery bypass grafting? A prospective comparison with the
echocardiography and FloTrac/Vigileo methods
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Background/aim: The aim of the current study was to assess the accuracy of cardiac output (CO) measurements obtained by the Nexfin
finger cuff method as compared with the FloTrac/Vigileo and echocardiography methods in coronary artery bypass grafting (CABG)
patients.
Materials and methods: First-time elective CABG patients were prospectively enrolled in this study and divided into three groups
according to CO measurement method. CO measurements were performed simultaneously by three different contributors and were
collected by the fourth one 24 h postoperative in the intensive care unit (ICU). Data were statistically analyzed.
Results: Seventeen female and 13 male patients between 42 and 78 years of age (with a mean of 56 ± 4) were the subjects of this
study. The mean CO measurements were 5.9 ± 1.4 L/min, 5.8 ± 1.1 L/min, and 6.0 ± 1.1 L/min for the Nexfin, FloTrac/Vigileo,
and echocardiography methods, respectively (P > 0.05). The correlation values between Nexfin and FloTrac/Vigileo, Nexfin and
echocardiography, and FloTrac/Vigileo and echocardiography were r = 0.445, r = 0.377, and r = 0.384, respectively (P < 0.05).
Conclusion: Nexfin yielded results comparable to those obtained with FloTrac/Vigileo and echocardiography for the postoperative CO
assessment of CABG patients. Nexfin may be used in uncomplicated, hemodynamically stable patients in ICU as a reliable and totally
noninvasive method of CO measurement.
Key words: Noninvasive monitoring, echocardiography, pulse contour analysis

1. Introduction
Cardiac output (CO) is the volume of blood pumped by
the heart per minute and is the product of heart rate (HR)
and stroke volume (SV) (1). Over the past decades, many
techniques for CO measurement have been developed and
used. CO is considered to be one of the most important
physiological parameters as the major determinant of
systemic oxygen delivery and cardiac function. Moreover,
it is a determinative factor for volume replacement therapy.
Its measurement is of great significance since so many
efforts in cardiovascular patients are aimed at optimizing
CO. The significance of measuring CO is emphasized by
studies that have repeatedly shown that clinical evaluation
and conventional monitoring alone are inaccurate and
unreliable for the evaluation of CO and that adequate
resuscitation cannot be based on stabilization of vital signs
* Correspondence: cemariturk.kvc@gmail.com

alone (2–6). An accurate and noninvasive measurement
of CO is one of the best methods of cardiovascular
assessment. There are a number of clinical methods
for CO measurement ranging from noninvasive ones
(echocardiography, Doppler) to invasive ones (SwanGanz technique, thermodilution technique, and arterial
pressure waveform analysis) (2,3). Each method has
its unique advantages and disadvantages and this leads
practitioners to further search for less invasive and equally
effective methods. For a CO measurement method to gain
widespread acceptance, obstacles such as physiological
limitations, troublesome maintenance, limited reliability,
and insufficient precision must be eliminated (7–11).
The aim of our study was to assess the accuracy of CO
measurements obtained by the finger cuff method (Nexfin
BMEYE B.V, Amsterdam, the Netherlands) (Nexfin) as
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compared with FloTrac/Vigileo (Edward Lifesciences,
Irvine, CA, USA) (FTV) and echocardiography (ECO) in
coronary artery bypass grafting (CABG) surgery patients.
2. Materials and methods
This prospective study was approved by the ethics
committee of the School of Medicine at Acıbadem
University in Turkey. Informed consent was obtained from
30 patients who were scheduled to undergo isolated firsttime CABG at the Acıbadem Healthcare Group, Kadıköy
Hospital.
2.1. Patient selection
The patients included in this study had a sinus rhythm
and stable hemodynamic conditions, and required no
inotropic or intraaortic balloon pump support. All had
CABG and were normothermic and extubated at the time
of CO measurement.
2.2. CO measurements
CO measurements by each method were simultaneously
obtained in the ICU in the morning of the first postoperative
day (20–24 h after admission to the ICU). Measurements
of CO were performed by three different contributors for
each method and recorded by a fourth one.
The method of Nexfin is based on the development
of pulsatile unloading of the finger arterial walls using
an inflatable finger cuff with a built-in photoelectric
plethysmograph. While continuously measuring arterial
blood pressure (ABP), the monitor also calculates CO.
The cuffs were placed in the middle phalanx of the second
finger of the patient’s left hand. ABP-based measurements
were performed with the FTV method. The right radial
artery was used for waveform analysis in each patient.
FTV was attached to the existing arterial cannula and its
sensor was attached to a display unit to assess CO.
ECO measurements of CO were performed by a single
cardiologist via transthoracic echocardiography evaluating
the velocity–time integral of the left ventricular outflow
tract (LVOT), HR, and LVOT area.

2.3. Data collection and statistical analysis
Prospectively collected demographic and hemodynamic
data (age, sex, mean arterial pressure, heart rate,
central venous pressure) and CO measurements were
retrospectively analyzed. Paired measurements of SVR,
SV, and CO were compared using Pearson’s correlation
coefficients; in addition, a Bland–Altman plot (12) was
used to graphically compare the agreement of pairs of
measurements of SVR, SV, and CO, using GraphPad Prism
v5.0. Data were reported as percentages or as means ± SD.
Statistical analysis was performed with SPSS and P < 0.05
was considered significant.
3. Results
Demographic data and hemodynamic parameters are
given in Table 1. Hemodynamic measurement results are
given in Table 2. The mean values of CO obtained with
Nexfin, FTV, and ECO techniques were 5.9 ± 1.4, 5.9 ± 1.1,
and 6.0 ± 1.1 L/min, respectively, and the mean values of
SV were 65 ± 15, 66 ± 11, and 70 ± 12 mL, respectively. The
mean systemic vascular resistance values were measured
as 1244 ± 468, 1102 ± 232, and 1042 ± 235 dyn s cm–5,
respectively. No significant differences were found among
the different techniques regarding CO, SV, and SVR (P >
0.05).
Figure 1a shows a Bland–Altman plot representing the
difference between the SVR measurements of FTV and
ECO (y-axis) against their means (x-axis) for all patients.
The mean difference (bias) between the two measurements
was –0.3376, with a 95% limit of agreement (–2.844, 2.169).
Figure 1b shows a Bland–Altman plot representing the
difference between the SVR measurements of Nexfin and
FTV (y-axis) against their means (x-axis) for all patients.
The mean difference (bias) between the two measurements
was 0.1041, with a 95% limit of agreement (–2.593, 2.802).
Figure 1c shows a Bland–Altman plot representing the
difference between the SVR measurements of Nexfin and
ECO (y-axis) against their means (x-axis) for all patients.
The mean difference (bias) between the two measurements
was –0.2335, with a 95% limit of agreement (–3.087, 2.620).

Table 1. Demographic data and hemodynamic parameters.
Nexfin

FloTrac/Vigileo

Echocardiography

58 ± 4

56 ± 5

53 ± 5

Sex (male/female)

04/06/15

5/5

4/6

Mean arterial pressure (mmHg)

73 ± 8

70 ± 12

72 ± 9

Heart rate (beats/min)

91 ± 7

89 ± 8

93 ± 6

Central venous pressure (mmHg)

9±4

8±3

9±5

Age
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Table 2. Mean values for all variables.
CO (L/min)

SV (mL)

SVR (dyn s cm–5)

5.85 ± 1.4

65 ± 15

1244 ± 468

FTV

5.75 ± 1.1

66 ± 11

1102 ± 232

ECO

6.0 ± 1.1

70 ± 12

1042 ± 235

Nexfin
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Figure 1. Bland–Altman plot between Nexfin, FTV, and ECO for CO (L): a) FVT–ECO, b) FTV–Nexfin, c) Nexfin–Eco.

Pearson’s rank correlation coefficients for the CO levels
measured with the different techniques are given in Table
3. The CO levels measured with Nexfin and FTV were
correlated (r = 0.445, P < 0.05), and so were the CO levels
measured with Nexfin and ECO (r = 0.377, P < 0.05) and
the CO levels measured with FTV and ECO (r = 0.384, P
< 0.05).
4. Discussion
During postoperative follow-up of patients who have
undergone cardiac surgery in which the pressure–volume
relationship has deteriorated, routinely used parameters
such as ABP and central venous pressure are insufficient
to assess the accuracy of tissue perfusion. In this subset
of patients advanced monitoring methods such as CO,
mixed venous oxygen saturation, and blood lactate level
measurements are suggested to assess the efficiency of
tissue perfusion (7).
Table 3. Pearson correlation values between methods of cardiac
output measurement.
Correlation coefficients

P-values

Nexfin–FTV

r = 0.445

P < 0.05

Nexfin–ECO

r = 0.377

P < 0.05

FTV–ECO

r = 0.384

P < 0.05

There are a number of clinical methods for CO
measurement ranging from direct pulmonary artery
catheterization to noninvasive measurements of arterial
pulse. Each of these invasive and noninvasive methods
has unique limitations, advantages, and disadvantages,
and the relative comparison is limited by the clinical
evaluation and hemodynamic stability of the patients
concerned (4–7). The effectiveness of a clinical monitoring
method involves many factors other than its absolute
accuracy, and includes safety, accessibility, adaptability,
and cost. In clinical care settings, many extensive research
studies were done in order to introduce new methods for
CO measurement with as few disadvantages as possible
(13–18). These techniques do not exclude or replace
the others as their advantages and limitations are quite
different. These noninvasive methods are not intended
to replace the pulmonary artery catheter, which is quite
unique in measuring the right atrium, pulmonary artery
and pulmonary wedge pressures, and the mixed venous
oxygen saturation, in addition to CO.
A comparison of arterial pressure waveform analysis
with thermodilution and ECO assessment was previously
conducted by Lorsomradee et al. (17). An overall agreement
has already been demonstrated for arterial pressure
waveform analysis and thermodilution techniques (14,18).
However, ECO assessment, especially during the early
postoperative period, may lead to overestimation of CO.
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Hence, ECO for CO measurement in the early postoperative
period may be questionable (19). CO measurement with
arterial waveform analysis may provide reliable results
with a less invasive technique and may increase the use
of CO analysis, thus improving perioperative patient care
(18). This knowledge encouraged us to compare Nexfin,
which is a relatively new method, with a well-known and
reliable method like FTV and a noninvasive method like
ECO.
De Wilde et al. (15) studied 13 CABG surgery
patients within 2 h of arrival to the ICU following cardiac
surgery. In that study the FTV Modelflow method and
the transesophageal ultrasonic HemoSonic system were
compared with an accurately performed thermodilution
method. The authors concluded that only the Modelflow
method was shown to be an acceptable alternative to the
thermodilution method for CO measurement. In another
recent study performed by Stover et al. (16), a standard
cardiac monitoring system (pulmonary artery catheter and
arterial catheter) was compared with Nexfin. The authors
noted that Nexfin, which is quick to install and easy to use,
could offer a quick initial hemodynamic overview and
save time until a longer-lasting invasive monitoring can be
installed in case of a deterioration in the patient cardiac
status. Nexfin, which is a relatively new, unique, and totally
noninvasive method (13), was shown to be reliable for
CO measurement either in critically ill patients (20) or in
cardiac surgery patients (21,22). The results of our study
also support the reliability of this noninvasive method for
CO measurement.

The ideal technique for CO monitoring would be
noninvasive, easily applied, accurate, reliable, consistent,
and compatible in postoperative cardiac patients in ICU.
Today, no single technique meets all these expectations.
With a Bland–Altman plot, we had the data of the
correlations between Nexfin, FTV, and ECO confirm that,
being correlated with the results of FTV and ECO, Nexfin
can be used reliably for patients in ICU after cardiac surgery
for the evaluation of patient tissue perfusion deterioration
despite the fact that patient arterial and central venous
pressures may remain normal.
In our study, all of the patients had preoperative ejection
fraction >35% and pulmonary capillary wedge pressure
<15 mmHg, and there was no postoperative hemodynamic
instability. Each patient was normothermic and free from
inotropes and vasopressors. The measurements of CO
were performed in uncomplicated conditions. These are
the limitations of our study.
In conclusion, the ability to accurately measure CO
is important in clinical medicine as it provides improved
diagnosis of abnormalities and can be used to guide
appropriate management of care, helping the clinician
in evaluating the problem and treating it before it affects
the patient’s hemodynamic stability. As Nexfin is a
totally noninvasive blood pressure and CO monitoring
method, it can be used for this purpose in uncomplicated
hemodynamically stable patients. However, further
studies should be conducted to confirm our preliminary
data, especially in hemodynamically unstable patients. The
widespread use of Nexfin would help avoid complications
associated with the invasive methods of CO measurement.
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